• No se han encontrado resultados

New vaccine for influenza virus H1N1 . Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina

N/A
N/A
Info
Descargar
Protected

Academic year: 2017

Share "New vaccine for influenza virus H1N1 . Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina"

Copied!
1
0
0

Cargando.... (Ver texto completo ahora)

Descargar ahora ( 1 página )

Texto completo

(1)

1644 ISSN 0326-2383

KEY WORDS: Adverse reactions, H1N1 Influenza, Pharmacovigilance, Vaccines.

* Author to whom correspondence should be addressed. E- mail: aliciabarca@yahoo.com.ar

Latin American Journal of Pharmacy

(formerly

Acta Farmacéutica Bonaerense)

Lat. Am. J. Pharm.

30

(8): 1644-7 (2011)

Short communication Received: June 16, 2011 Revised version: June 30, 2011 Accepted: July 1, 2011

New Vaccine for Influenza Virus H1N1: Pharmacosurveillance

of Adverse Reactions in Health Staff at Hospital San Luis, Argentina

Alicia N. AVILA

1

*, Natalia VIDELA

1

, Jesica A. COLLADO

1

,

Elisabeth S. BALLERINO MONTACCI

1

& María G. SARMIENTO

2

1

Servicio de Farmacia;

2

Epidemiología, Nodo Epidemiológico.

Hospital San Luis. Héroes de Malvinas 110- 5700, San Luis Argentina

Referencias

Descargar ahora ( PDF - 1 página - 36.35 KB )

Documento similar

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

In other clinical trials evaluating ZOSTAVAX in subjects 50 years of age or older, including a study of concomitantly administered inactivated influenza vaccine, a higher rate

].TheHRQoLassessmentincorporatesatearlyages theimpactthesehaveonhishealthstatus.Itischaracterizedassubjective,multidimen-sional,andchangingovertime[ EffectofCOVID-19onHealth-RelatedQualityofLifeinAdolescentsandChildren:ASystematicReview

Abstract: The aim of the present systematic review was to assess and provide an up-to-date analysis of the impact of coronavirus disease 2019 (COVID-19) pandemic on the

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

INTANZA is at least as immunogenic as the comparator trivalent inactivated influenza vaccine administered by intramuscular route for each of the 3 influenza strains in subjects from

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The safety experience with trivalent Fluenz is relevant to the use of Fluenz Tetra because Fluenz Tetra (influenza vaccine-live attenuated, nasal) is identical to Fluenz with the

Factors Associated with Asthma Control in Primary Care Patients in Spain: The CHAS study

The objective of the Control and Handling of Asthma in Spain (CHAS) study was to evaluate the prevalence of uncontrolled asthma in primary care patients as well as to identify

This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices

a) Maintain detailed records of all suspected adverse reactions occurring in Spain or in the European Union or a third country. Save in exceptional circumstances, such as

Hazard, death and sequels: perception on severe preeclampsia by those who lived it Peligro, muerte y secuelas: percepción de la preeclampsia severa por quienes la han vivido:

Objective: To describe perception about severe preeclampsia and its causality in a group of women who lived the disease and were attended at Hospital de San

VaccinationadjuvatedagainsthepatitisBinSpanishNationalHealthcareSystem(SNS)workerstypedasnon-responderstoconventionalvaccines Vaccine

The objective of this study was to provide Health workers- staff with an additional protection tool against hepatitis B infection, and to evaluate the efficacy of the adjuvanted